J. Goldman & Co’s Immunogen Inc IMGN Stock Holding History

J. Goldman & Co’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,004,876	Closed	-$4.82M	–	348
2018 Q4	$4.82M	Buy	1,004,876 +708,763	+239%	+$4.3M	0.37%	80
2018 Q3	$2.8M	Buy	+296,113	New	+$2.85M	0.2%	130

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

J. Goldman & Co's IMGN Position: Q1 2019 in Review

J. Goldman & Co sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 1,004,876 shares — an estimated $4.82M sold.

J. Goldman & Co first reported a position in IMGN in Q3 2018 and held it in 2 quarters. The position peaked at $4.82M in Q4 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

J. Goldman & Co reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
J. Goldman & Co sold 1,004,876 Immunogen Inc shares in Q1 2019, an estimated $4.82M.
J. Goldman & Co first reported a position in Immunogen Inc in Q3 2018 and held it in 2 quarters.
J. Goldman & Co's Immunogen Inc position peaked at $4.82M in Q4 2018.
212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.